Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1250 of 1561 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/01/19
Due: 12/01/20
Phase: N/A
Priority: Normal
Start: 06/04/22
End: 02/10/24
Due: 02/10/25
Phase: N/A
Priority: Normal
Start: 03/06/19
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 03/20/23
End: 07/20/23
Due: 07/20/24
Phase: N/A
Priority: Normal
Start: 04/09/23
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 08/16/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/08/21
End: 12/07/22
Due: 12/07/23
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 09/28/18
Due: 09/28/19
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 09/28/24
Due: 09/28/25
Phase: N/A
Priority: Normal
Start: 03/10/24
End: 09/10/24
Due: 09/10/25
Phase: N/A
Priority: Normal
Start: 10/10/22
End: 04/20/23
Due: 04/20/24
Phase: N/A
Priority: Normal
Start: 05/01/24
End: 10/01/24
Due: 10/01/25
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 09/01/21
Due: 09/01/22
Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.
Phase: N/A
Priority: Normal
Start: 06/15/24
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 03/15/22
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 08/01/16
End: 02/01/18
Due: 02/01/19
Phase: N/A
Priority: Normal
Start: 12/20/23
End: 10/20/25
Due: 10/20/26
Phase: N/A
Priority: Normal
Start: 02/12/24
End: 03/31/25
Due: 03/31/26